During tumor progression, angiogenesis is a complex process often triggered by hypoxia, which leads to increases in angiopoietin, vascular endothelial growth factor (VEGF), and hypoxia-inducing factor (HIF-1) levels. Here, VEGFA is linked to neoplasm.